We are live on ! Find out more
ENTL

Entellus Medical, Inc. Common Stock
ENTL

Delisted

ENTL was delisted on the 27th of February, 2018.

52 hedge funds and large institutions have $199M invested in Entellus Medical, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

2% less funds holding

Funds holding: 5352 (-1)

7% less capital invested

Capital invested by funds: $214M → $199M (-$15.4M)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
1.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
7
Increased
19
Reduced
11
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$64.3M
SHI
2
SV Health Investors
Massachusetts
$58.8M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$15.1M -$665K -39,159 -4%
RIM
4
RS Investment Management
California
$7.88M -$10.9M -640,416 -58%
Wells Fargo
5
Wells Fargo
California
$7.83M +$528K +31,082 +7%
FLAM
6
First Light Asset Management
Minnesota
$6.6M +$2.53M +148,965 +61%
KCM
7
Kingdon Capital Management
New York
$5.05M +$497K +29,268 +11%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$4.5M +$146K +8,610 +3%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$4.5M +$4.53M +266,630 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.13M +$288K +16,965 +10%
GTC
11
Ghost Tree Capital
New York
$2.53M +$2.55M +150,000 New
BFA
12
BlackRock Fund Advisors
California
$2.48M +$68.1K +4,011 +3%
WA
13
Wasatch Advisors
Utah
$2.39M +$472K +27,766 +24%
Ameriprise
14
Ameriprise
Minnesota
$2.38M +$1.49M +87,825 +165%
Federated Hermes
15
Federated Hermes
Pennsylvania
$1.74M +$770K +45,343 +79%
BIT
16
BlackRock Institutional Trust
California
$1.6M +$141K +8,292 +10%
Northern Trust
17
Northern Trust
Illinois
$993K +$1.87K +110 +0.2%
MRM
18
Michael R. Murphy
$893K +$900K +52,971 New
PI
19
Putnam Investments
Massachusetts
$795K -$12.1K -713 -1%
State Street
20
State Street
Massachusetts
$791K +$36.2K +2,132 +5%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$648K +$31.4K +1,846 +5%
FA
22
Friess Associates
Delaware
$582K +$586K +34,500 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$427K
BIM
24
BlackRock Investment Management
Delaware
$336K +$1.19K +70 +0.4%
KeyBank National Association
25
KeyBank National Association
Ohio
$328K +$103K +6,085 +45%

ENTL Hedge Fund Activity: Q4 2015 in Review

52 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q4 2015, worth a combined $199M — down 7.2% from $214M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ENTL and 7 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 19 added.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $4.53M. The largest seller was RS Investment Management, cutting an estimated $10.9M.

  • 52 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q4 2015, down from 53 in Q3 2015.
  • Funds reported $199M of Entellus Medical, Inc. Common Stock stock for Q4 2015, down 7.2% quarter-over-quarter.
  • 7 funds opened new Entellus Medical, Inc. Common Stock positions in Q4 2015 and 8 closed out, a net change of -1 holder.
  • The largest Entellus Medical, Inc. Common Stock buyer in Q4 2015 was Adage Capital Partners, an estimated $4.53M added.
  • The largest Entellus Medical, Inc. Common Stock seller in Q4 2015 was RS Investment Management, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2015.